All In MedTech

Device Trial Radar · NCT06149000

Migraine Headache Mitigation Utilizing Avulux

Migraine Headache Mitigation Utilizing Avulux Color Filtering Lenses

Last checked: Nov 19, 2026Latest source record: Nov 28, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

40

Planned (sponsor's estimate)

Start

Dec 13, 2023

Primary completion

Jun 13, 2024

Study completion Jun 20, 2024

Sponsor

Lead sponsor
Kaiser PermanenteAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Nov 28, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Crossover
Masking
Double (participant, investigator)
Primary purpose
Prevention
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 120 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This will be a randomized double blind cross over interventional trial to determine if Avulux lenses are able to reduce headache symptoms in patients

Conditions

  • Migraine
  • Headache
  • Photophobia

Interventions

  • Avulux LensesDevice

    Avulux lenses are specialized eyewear designed to reduce specific wavelengths of light to alleviate symptoms in individuals who experience light sensitivity and migraines

  • Placebo LensesDevice

    Lenses that will look identical to Avulux lenses without the medical benefits

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Reduction in migraine frequencyTime frame: 6 months
  2. Reduction in migraine severityTime frame: 6 months

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.